Tech Company Financing Transactions

Vitasense Funding Round

On 3/3/2025, Vitasense raised financing from Crown Wealth and private investors.

Transaction Overview

Company Name
Announced On
3/3/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to refine its third-generation prototype, enhance regulatory compliance efforts, and prepare for large-scale clinical testing.

Company Information

Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
Undisclosed
Philadelphia, PA Undisclosed
USA
Email Address
Overview
VitaSense, a groundbreaking glucose monitoring armband, addresses the pressing issue of undiagnosed diabetes by offering a non-invasive and pain-free alternative to traditional finger pricking methods. Utilizing advanced materials like Germanium Selenide (GeSe) nanomaterials, photoplethysmography, and semiconductor-based sensors, the device ensures accurate and real-time glucose level monitoring without the discomfort associated with needles.
Profile
Vitasense LinkedIn Company Profile
Social Media
Vitasense Company Twitter Account
Company News
Vitasense News
Facebook
Vitasense on Facebook
YouTube
Vitasense on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Max Kopp
  Max Kopp LinkedIn Profile  Max Kopp Twitter Account  Max Kopp News  Max Kopp on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/3/2025: FairPlay venture capital transaction
Next: 3/4/2025: myTU venture capital transaction

 

Share this article

 


Where The Data Comes From

We record every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary